| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 03/25/2004 | WO2004024283A2 Apparatus and method for preparative scale purification of nucleic acids |
| 03/25/2004 | WO2004024084A2 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 03/25/2004 | WO2004024076A2 Novel compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024068A2 Novel composition and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024064A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004024063A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004007719A8 Use of sumo- and ubiquitin-modified pcna for detection and channeling of dna transaction pathways |
| 03/25/2004 | WO2004007670A3 RECOMBINANT TYPE II RESTRICTION ENDONUCLEASES, MmeI AND RELATED ENDONUCLEASES AND METHODS FOR PRODUCTING THE SAME |
| 03/25/2004 | WO2004003135A3 Selective cloning of homoduplex nucleic acids |
| 03/25/2004 | WO2003102174A3 Modified phytases |
| 03/25/2004 | WO2003093485A3 Optimization of transgene expression in mammalian cells |
| 03/25/2004 | WO2003093424A3 In vivo ssdna expression vectors for altering gene expression |
| 03/25/2004 | WO2003093406A3 Microfermentors for rapid screening and analysis of biochemical processes |
| 03/25/2004 | WO2003088996A3 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines |
| 03/25/2004 | WO2003087330A3 Vac-bac shuttle vector system |
| 03/25/2004 | WO2003083098A3 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy |
| 03/25/2004 | WO2003077844A3 Effect of treatment with 4,5-dihydroxy- 2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria |
| 03/25/2004 | WO2003075747A3 Contrast agents for magnetic resonance imaging and methods related thereto |
| 03/25/2004 | WO2003072044A3 Selection of poultry eimeria strains through extra-intestinal sporozoites |
| 03/25/2004 | WO2003068978A3 Combinations of vectors and the hosts thereof for the propagation and expression of recombinant genes without recourse to antibiotics |
| 03/25/2004 | WO2003059374A3 Use of dimer-specific nuclear localisation signal peptides (dsnls) derived from the stat dna binding domain |
| 03/25/2004 | WO2003056023A8 Double-stranded cyclic dna capable of proliferating as artificial e. coli chromosome |
| 03/25/2004 | WO2003054156A3 Novel g proein-coupled receptor, gave7 |
| 03/25/2004 | WO2003051923A3 Novel g-protein coupled receptors and dna sequences thereof |
| 03/25/2004 | WO2003035828A3 Method for cloning and expression of tspri restriction endonuclease and tspri methylase in e. coli |
| 03/25/2004 | WO2003033680A3 Kinases and phosphatases |
| 03/25/2004 | WO2003031475A3 Antibodies against kdr, their production and uses |
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | WO2003012074A3 Bacterial strains belonging to lactobacillus species and their use in food and feed industry |
| 03/25/2004 | WO2002096942A3 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof |
| 03/25/2004 | WO2002092797A3 Alpha-amylase variant with altered properties |
| 03/25/2004 | WO2002083859A8 Surface proteins of streptococcus pyogenes |
| 03/25/2004 | WO2002079492A8 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
| 03/25/2004 | WO2002074048A3 P-glycoproteins and uses thereof |
| 03/25/2004 | WO2002072832A3 Therapeutic binding molecules |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002055557A3 Human proteins and nucleic acids encoding same |
| 03/25/2004 | WO2002034288A8 Vaccine for treating allergy |
| 03/25/2004 | US20040059103 Comprises nucleotide sequences coding tyrosine ammonia lyase (TAL) for production of para-hydroxycinnamic acid (pHCA) in transgenic cells |
| 03/25/2004 | US20040059090 Novel compounds |
| 03/25/2004 | US20040058860 Novel bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 03/25/2004 | US20040058448 Transgenic gram negative bacteria for production of oligo and/or polysaccharides; gene therapy and vaccine development |
| 03/25/2004 | US20040058435 Organic waste fermentatively-processing device |
| 03/25/2004 | US20040058428 Selective growth medium for Bacillus anthracis and methods of use |
| 03/25/2004 | US20040058426 Comprises phosphorylation enzyme for diagnosis, prevention and treatment of immunological, cancer, lipid and cardiovascular diseases |
| 03/25/2004 | US20040058419 Thermostable L-arabinose isomerase and process for preparing D-tagatose |
| 03/25/2004 | US20040058418 Allowing an enzyme source, an acceptor complex carbonhydrate and guanosine diphosphofucose to be present in an aqueous medium, transferring fucose to acceptor complex carbohydrate by alpha-1,2 linkage to form complex |
| 03/25/2004 | US20040058415 Preparing modified/artificial polypeptides; mimetics |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040058411 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058410 Fermentative carotenoid production |
| 03/25/2004 | US20040058403 Using high speed fluorescence activated cell sorting (FACS) to isolate bacterial cells expressing ligand binding polypeptides |
| 03/25/2004 | US20040058398 Pancreatic progenitor cells and methods for isolating the same |
| 03/25/2004 | US20040058371 Novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 03/25/2004 | US20040058366 Comprises DNA coding brain-muscle-arnt-like protein 2 (BMAL2) for diagnosis and treatment of circadian rythm disorders |
| 03/25/2004 | US20040058362 Polymerase chimeras |
| 03/25/2004 | US20040058361 Antibacterial treatments |
| 03/25/2004 | US20040058358 Lipid metabolism transcription factor |
| 03/25/2004 | US20040058353 Comprises nucleotide sequences coding transport proteins for diagnosis and treatment of pain, psychotic, eating and nervous system disorders |
| 03/25/2004 | US20040058348 Mesophilic bacterial heat resistant regulatory sequences for use as transfer tool in genetic engineering |
| 03/25/2004 | US20040058344 Transgenic cells comprising precursor messenger RNA for diagnosis of infectious, cell proliferative, nervous system and metabolic disorders |
| 03/25/2004 | US20040058342 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |
| 03/25/2004 | US20040058340 Diagnosis and prognosis of breast cancer patients |
| 03/25/2004 | US20040058338 Novel proteins and nucleic acids encoding same |
| 03/25/2004 | US20040058323 Proteins with repetitive bacterial-Ig-like (big) domains present in leptospira species |
| 03/25/2004 | US20040058319 Comprises nucleotide sequences coding urogenital polypeptide for diagnosis and treatment cancer |
| 03/25/2004 | US20040058316 Use of recombinant antigens to determine the immune status of an animal |
| 03/25/2004 | US20040057966 RecA mutant mycobacteria, particularly mutants of mycobacterial species which are members of the Mycobacterium tuberculosis complex, such as M.bovis BCG and M.tuberculosis; immunotherapteutic agents, vaccines, for tuberculosis |
| 03/25/2004 | US20040057953 Modified peptides as therapeutic agents |
| 03/25/2004 | US20040057943 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 03/25/2004 | US20040057934 Therapeutic agent for treating retroviral infection |
| 03/25/2004 | US20040057925 Methods of enhancing bioactivity of chemokines |
| 03/25/2004 | US20040055953 Enzyme is produced by a fungus of the genus Penicillium restrictum isolated from agribusiness wastes, used for the treatment of liquid, paste, semi-solid effluents, both domestic/industrial containing fats, proteins, carbohydrates |
| 03/25/2004 | CA2499221A1 Rapidly degraded reporter fusion proteins |
| 03/25/2004 | CA2498928A1 Rb pathway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 03/25/2004 | CA2498771A1 2',5'-oligoadenylate phosphodiesterase |
| 03/25/2004 | CA2498518A1 Apparatus and method for preparative scale purification of nucleic acids |
| 03/25/2004 | CA2498502A1 Recombinant clostridial toxin fragments with proteolytic activation |
| 03/25/2004 | CA2498200A1 Construction of bacillus licheniformis t1 strain and fermentation production of crude enzyme extract therefrom |
| 03/25/2004 | CA2498008A1 Novel composition and methods for the treatment of immune related diseases |
| 03/25/2004 | CA2498004A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | CA2498000A1 Use of tumor-associated kinase (task) 110 antagonists for treating pancreatic cancers |
| 03/25/2004 | CA2497661A1 Compositions and methods for the diagnosis of immune related diseases using pro71061 |
| 03/25/2004 | CA2494976A1 A sieve tube-localized glutathione s-transferase |
| 03/24/2004 | EP1400593A1 Novel promoter |
| 03/24/2004 | EP1400592A1 Streptococcus pneumoniae polynucleotides and sequences |
| 03/24/2004 | EP1400586A1 Substrates containing a trichoderma asperellum strain for biological control of fusarium and rhizoctonia |
| 03/24/2004 | EP1400532A1 M. paratuberculosis specific ABC-transporter operon |
| 03/24/2004 | EP1399574A2 Improved vectors for gene therapy |
| 03/24/2004 | EP1399570A2 Peptides for use as translocation factors |
| 03/24/2004 | EP1399568A2 Method for producing recombinant trypsin |
| 03/24/2004 | EP1399567A1 Method for producing alpha-hydroxy acid, glycolic acid 2-hydroxyisobutyric acid from a corresponding alpha-hydroxy nitrile using nitrilase |
| 03/24/2004 | EP1399565A2 Mitogenic oxygenase regulators |
| 03/24/2004 | EP1399564A2 Drug metabolizing enzymes |
| 03/24/2004 | EP1399563A2 Moraxella (branhamella) catarrhalis antigens |
| 03/24/2004 | EP1399560A2 Engineered human kunitz-type protease inhibitor |
| 03/24/2004 | EP1399558A2 Vanilloid receptor-related nucleic acids and polypeptides |
| 03/24/2004 | EP1399557A2 Brain expressed gene and protein associated with bipolar disorder |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399552A2 G-protein coupled receptor proteins (gpcr) and nucleic acids encoding same |